Entity

Time filter

Source Type


Trademark
Viventia Biotechnologies Inc. and Viventia Biotech Inc. | Date: 2012-08-07

Biotechnology preparations for commercial purposes, namely, for use in the manufacture of biopharmaceutical and biotechnology products; diagnostic preparations for laboratory and/or medical research purposes; nucleic acids for laboratory use; biological tissue, namely, stem cells for scientific and medical research use; protein arrays for scientific and medical research; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use. Biopharmaceutical preparations and biotechnology preparations for medical purposes for the treatment of malignant and/or benign tumors; cancer; immune diseases, including autoimmune, inflammatory diseases, infectious diseases and vascular diseases; synthetic polypeptides for biopharmaceutical purposes; vaccines; diagnostic preparations for medical purposes; diagnostic preparations, namely, monoclonal antibodies, human antibodies, immune toxins; toxin proteins, and proteins for clinical or medical laboratory use. Medical and scientific research and development services, namely, preparation and development of proteins and preparation and development services, namely, preparation and development of proteins and preparation and development of in vitro generated recombinant antibodies and proteins, and fragments thereof; product development services for others; preparation and screening of libraries of proteins and antibodies, libraries of cells producing antibodies and proteins, and libraries of vector coding for antibodies and proteins.


Trademark
Viventia Biotechnologies Inc. and Viventia Biotech Inc. | Date: 2011-11-03

Biotechnology preparations for commercial purposes, namely, recominant-generated antibodies and recominant fragments thereof for commercial purposes; biopharmaceutical and biotechnology products; diagnostic preparations for laboratory and medical research purposes; nucleic acids for laboratory use; biological tissue, namely, stem cells for scientific and medical research use; protein arrays for scientific and medical research; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic preparations for scientific use, namely, monoclonal antibodies, human antibodies, immune toxins; proteins for clinical or medical laboratory use. Biopharmaceutical preparations and biotechnology preparations for medical purposes for the treatment of malignant and benign tumors; cancer; immune diseases, including autoimmune, inflammatory diseases, infectious diseases and vascular diseases; synthetic polypeptides for biopharmaceutical purposes; vaccines; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes, namely, monoclonal antibodies, human antibodies, immune toxins; toxin proteins, and proteins for clinical or medical laboratory use. Medical and scientific research and development services, namely, preparation and development of proteins and in vitro generated recombinant antibodies and proteins, and fragments thereof; product development services for others in the field of medical and scientific research and development; medical laboratory services, namely, preparation and screening of libraries of proteins and antibodies, libraries of cells producing antibodies and proteins, and libraries of vector coding for antibodies and proteins.


Patent
Viventia Biotechnologies Inc. | Date: 2011-04-26

The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.


Patent
Viventia Biotechnologies Inc. | Date: 2013-01-25

The present invention provides a novel cancer-associated antigen that can be used in the treatment and diagnosis of cancer. Further, the invention provides amino acid and nucleic acid sequence of the novel antigen, binding proteins, and immunoconjugates. The invention also relates to diagnostic and therapeutic methods and kits.


Patent
Viventia Biotechnologies Inc. | Date: 2013-01-17

The present invention provides the amino acid and nucleic acid sequences of heavy chain and light chain complementarity determining regions of a tumor specific antibody. In addition, the invention provides tumor-specific antibodies and immunoconjugates comprising the tumor-specific antibody attached to a toxin or label, and methods and uses thereof. The invention also relates to diagnostic methods and kits using the tumor-specific antibodies of the invention.

Discover hidden collaborations